Two important goals of our COBRE Phase III proposal are to sustain a collaborative multidisciplinary research environment by providing support for pilot projects and to encourage and facilitate collaborative interactions between basic science and clinical/translational investigators. Accordingly, the pilot project component will provide research opportunities for novel, innovative, highly competitive meritorious projects with high likelihood for garnering extramural research support. Projects that have the potential of significantly expanding the scope of current research efforts and stimulating collaborative multidisciplinary research and new clinical/translational projects will be given priority. It is anticipated that most applications will be from scientists in departments from the Medical School (Physiology, Pharmacology, Medicine, Pediatrics), the School of Public Health and Tropical Medicine (Epidemiology) and the School of Science and Engineering (Biomedical Engineering). Projects that address important, novel and significant issues related to the broad area encompassed by hypertension, renal and cardiovascular research will be considered. Applications will be subjected to a rigorous internal and external review process to ensure that funds are provided only to highly meritorious pilot projects that are likely to lead to extramural research support and will stimulate multidisciplinary collaborative interactions. It is important to provide sufficient funds to allow a timely development of preliminary data in order to meet grant deadlines. Thus, we propose to provide up to $50,000 per pilot project to support one year research efforts. This program will encourage submission of interdisciplinary grant proposals, and result in increased productivity as reflected by presentations at national meetings and publications in peer reviewed journals. The pilot projects program will stimulate faculty to undertake research in hypertension, renal and cardiovascular diseases and thus expand the activities of the parent program. Furthermore, these grants will help Tulane retain the most talented and qualified scientists in our area of research thus contributing to a sustainable productive research environment of the highest quality.

Public Health Relevance

Hypertension is a leading cause of death and disability affecting over 50 million people in the United States and responsible for 200,000 deaths annually. The pilot projects section of this program will fund highly competitive research grants that will expand the scope of research by encouraging multidisciplinary research projects in both basic science and clinical/translational research.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
5P30GM103337-02
Application #
8517765
Study Section
Special Emphasis Panel (ZRR1-RI-B)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
2
Fiscal Year
2013
Total Cost
$214,348
Indirect Cost
$71,924
Name
Tulane University
Department
Type
DUNS #
053785812
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Cedillo-Couvert, Esteban A; Ricardo, Ana C; Chen, Jinsong et al. (2018) Self-reported Medication Adherence and CKD Progression. Kidney Int Rep 3:645-651
Liu, Hongbing; Chen, Shaowei; Yao, Xiao et al. (2018) Histone deacetylases 1 and 2 regulate the transcriptional programs of nephron progenitors and renal vesicles. Development 145:
Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451
Dobre, Mirela; Gaussoin, Sarah A; Bates, Jeffrey T et al. (2018) Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults. Clin J Am Soc Nephrol 13:596-603
Shapiro, Brian P; Ambrosius, Walter T; Blackshear, Joseph L et al. (2018) Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension 71:1064-1074
Rocco, Michael V; Sink, Kaycee M; Lovato, Laura C et al. (2018) Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis 71:352-361
Beddhu, Srinivasan; Greene, Tom; Boucher, Robert et al. (2018) Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials. Lancet Diabetes Endocrinol 6:555-563
Anderson, Christopher E; Hamm, L Lee; Batuman, Gem et al. (2018) The association of angiogenic factors and chronic kidney disease. BMC Nephrol 19:117
Lightell Jr, Daniel J; Moss, Stephanie C; Woods, T Cooper (2018) Upregulation of miR-221 and -222 in response to increased extracellular signal-regulated kinases 1/2 activity exacerbates neointimal hyperplasia in diabetes mellitus. Atherosclerosis 269:71-78
Dungan, Kathleen; Craven, Timothy E; Soe, Kyaw et al. (2018) Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort. Diabetes Obes Metab 20:629-637

Showing the most recent 10 out of 240 publications